Apoptosis as a tool for therapeutic agents in haematological diseases (Q35684882)

9 August 2017

1 reference

title

Apoptosis as a tool for therapeutic agents in haematological diseases (English)

1 reference

9 August 2017

Faris Q B Alenzi

1

1 reference

9 August 2017

Richard K H Wyse

series ordinal

2

1 reference

9 August 2017

Waleed G Altamimi

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Expert Opinion on Biological Therapy

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

407-420

1 reference

Programmed cell death, apoptosis and killer genes

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Apoptosis and disease: regulation and clinical relevance of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Caspase-3 activation is an early event and initiates apoptotic damage in a human leukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Cellular and molecular themes in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Differential apoptosis and Fas expression on GPI‐negative and GPI‐positive stem cells: a mechanism for the evolution of paroxysmal nocturnal haemoglobinuria*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

A family of ligands for the TNF receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The genes of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The role of Fas ligand in immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

CD95 antigen mutations in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Bcl-G, a novel pro-apoptotic member of the Bcl-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

bcl-2 inhibits death of central neural cells induced by multiple agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Expression of Bcl-x in erythroid precursors from patients with polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Bcl-2 mRNA-targeted ribozymes: effects on programmed cell death in chronic myelogenous leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Thymocyte apoptosis induced by p53-dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Modulation of cell kinetics and cell cycle status by treating CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The role of myc in transformation by BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

From bench to clinic with apoptosis-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The myelodysplastic syndromes: a matter of life or death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Ajoene, an experimental anti-leukemic drug: mechanism of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The potential for immunoconjugates in lymphoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Antibodies as cytotoxic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

STI571 as a targeted therapy for CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Gene therapy for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.3.407

21 January 2018

Identifiers

DOI

10.1517/14712598.4.3.407

1 reference

9 August 2017

1 reference